The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...

*For a limited time only. $2,000 off and a free toilet (install included) with the purchase and installation of a Safe Step Walk-In Tub. Note alternative offer of $1,000 off and a free toilet (install ...

Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Thom Dunn Thom Dunn is a ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...